Cuban Biotech to the Rescue: The Story of a Potential Anti-COVID-19 Drug Told By One of Its Creators | WHAT REALLY HAPPENED

Cuban Biotech to the Rescue: The Story of a Potential Anti-COVID-19 Drug Told By One of Its Creators

The Cuban biotech industry has offered its own tool to fight the coronavirus disease. Dr. Manuel Limonta, one of the founding fathers of Cuba's biotechnology initiative, has explained how the island nation has mastered itself in producing interferon, a drug chosen by a number of countries to treat COVID-19.

Amid the media buzz about hydroxychloroquine, an anti-malaria drug lauded by Donald Trump as a potential cure against COVID-19, recombinant interferon remains neglected despite being one of medicines which have proven effective in curbing China's coronavirus epidemic.

Interferons (IFN) are the group of signalling proteins produced by cells to trigger defences of a human immune system in the event of viral attacks. Discovered in 1957 they were named for their ability to "interfere" with the infection process by protecting cells from pathogens. Since then, biotechnologists found the way to artificially produce the substance it has been used as a part of complex treatment against such severe illnesses as HIV, cancer, hepatitis B, hepatitis C, pneumococcal invasive diseases, and considered instrumental against SARS-Cov and MERS-Cov.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA